Susquehanna International Group’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-187
Closed -$16K – 12949
2022
Q1
$16K Sell
187
-947
-84% -$90.2K ﹤0.01% 12678
2021
Q4
$145K Sell
1,134
-636
-36% -$124K ﹤0.01% 11825
2021
Q3
$411K Sell
1,770
-1,160
-40% -$326K ﹤0.01% 9862
2021
Q2
$1.11M Buy
+2,930
New +$961K ﹤0.01% 7465

Other funds holding CALC

Susquehanna International Group's CALC Position: Q2 2026 in Review

Susquehanna International Group increased its CalciMedica (CALC) stake by 43% in Q2 2026, buying an estimated $9.4K and bringing the position to 8,794 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12862.

Susquehanna International Group first reported a position in CALC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.46M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Susquehanna International Group held 8,794 shares of CalciMedica worth $45.3K as of Q2 2026.
  • Susquehanna International Group bought 2,651 CalciMedica shares in Q2 2026, an estimated $9.4K.
  • CalciMedica made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12862 holding.
  • Susquehanna International Group first reported a position in CalciMedica in Q2 2021 and has held it in 7 quarters since.
  • Susquehanna International Group's CalciMedica position peaked at $1.46M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.